Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone vs prednisone + ciclosporin vs prednisone + methotrexate in new-onset juvenile dermatomyositis (5-year phase III)
2005-003956-37Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in juvenile dermatomyositis (JDM) comparing Prednisone monotherapy, Prednisone + ciclosporin and Prednisone + methotrexate (3 arms). Primary endpoint: Primary effectiveness endpoint. Started Jun 2006; status: active.
02
Drugs
prednisonecyclosporinemethotrexate
03
Conditions
juvenile dermatomyositis (JDM)
Beyond the preview
Go deeper on 2005-003956-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003956-37.